PT1146897E - Utilizacao de um factor de actividade inibidora de melanomas (mia) para reparacao de cartilagem e de osso - Google Patents

Utilizacao de um factor de actividade inibidora de melanomas (mia) para reparacao de cartilagem e de osso

Info

Publication number
PT1146897E
PT1146897E PT00906234T PT00906234T PT1146897E PT 1146897 E PT1146897 E PT 1146897E PT 00906234 T PT00906234 T PT 00906234T PT 00906234 T PT00906234 T PT 00906234T PT 1146897 E PT1146897 E PT 1146897E
Authority
PT
Portugal
Prior art keywords
mia
cartilage
bone repair
inhibitor activity
melanoma inhibitor
Prior art date
Application number
PT00906234T
Other languages
English (en)
Inventor
Carola Dony
Ulrike Leser
Gabriele Proetzel
Original Assignee
Carola Dony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carola Dony filed Critical Carola Dony
Publication of PT1146897E publication Critical patent/PT1146897E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT00906234T 1999-01-28 2000-01-27 Utilizacao de um factor de actividade inibidora de melanomas (mia) para reparacao de cartilagem e de osso PT1146897E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99101315A EP1025871A1 (en) 1999-01-28 1999-01-28 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair

Publications (1)

Publication Number Publication Date
PT1146897E true PT1146897E (pt) 2003-02-28

Family

ID=8237403

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00906234T PT1146897E (pt) 1999-01-28 2000-01-27 Utilizacao de um factor de actividade inibidora de melanomas (mia) para reparacao de cartilagem e de osso

Country Status (11)

Country Link
US (1) US6890897B1 (pt)
EP (2) EP1025871A1 (pt)
JP (2) JP4800483B2 (pt)
AT (1) ATE224731T1 (pt)
AU (1) AU765929B2 (pt)
CA (1) CA2361238C (pt)
DE (1) DE60000501T2 (pt)
DK (1) DK1146897T3 (pt)
ES (1) ES2180514T3 (pt)
PT (1) PT1146897E (pt)
WO (1) WO2000044401A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035128A1 (fr) * 2001-10-25 2003-05-01 Japan Science And Technology Agency Substance biologique composite
WO2003066083A1 (fr) * 2002-02-04 2003-08-14 Sumitomo Pharmaceuticals Company, Limited Preparations pour le traitement de fracture osseuse de deperdition osseuse ou d'augmentation la densite osseuse
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
NZ571113A (en) 2005-11-17 2012-02-24 Biomimetic Therapeutics Inc Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
CA2641860C (en) 2006-02-09 2015-07-14 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
CA2656278C (en) 2006-06-30 2016-02-09 Biomimetic Therapeutics, Inc. Compositions and methods for treating rotator cuff injuries
US7671014B2 (en) * 2006-08-14 2010-03-02 Warsaw Orthopedic, Inc. Flowable carrier matrix and methods for delivering to a patient
ES2708851T3 (es) * 2006-10-06 2019-04-11 Bionet Pharma Gmbh Un implante del núcleo pulposo espinal
WO2008073628A2 (en) 2006-11-03 2008-06-19 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
AU2009212151C1 (en) 2008-02-07 2015-09-17 Biomimetic Therapeutics, Llc Compositions and methods for distraction osteogenesis
US9616153B2 (en) 2008-04-17 2017-04-11 Warsaw Orthopedic, Inc. Rigid bone graft substitute
NZ602861A (en) 2008-09-09 2014-03-28 Biomimetic Therapeutics Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
EP2538791B1 (en) 2010-02-22 2015-04-08 BioMimetic Therapeutics, LLC Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
EP2563809B1 (en) 2010-04-27 2020-04-01 Scil Technology GmbH Stable aqueous mia/cd-rap formulations
WO2018129470A1 (en) * 2017-01-09 2018-07-12 The Board Of Trustees Of The Leland Stanford Junior University Reversing deficient hedgehog signaling restores deficient skeletal regeneration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919929A (en) * 1984-02-01 1990-04-24 Stolle Research & Development Corporation Mammal immunization
AU651421B2 (en) * 1990-11-30 1994-07-21 Celtrix Pharmaceuticals, Inc. Use of a bone morphogenetic protein in synergistic combination with TGF-beta for bone repair
AU7531294A (en) * 1993-07-20 1995-02-20 Boehringer Mannheim Gmbh Melanoma-inhibiting protein
TW369414B (en) * 1994-09-30 1999-09-11 Yamanouchi Pharma Co Ltd Bone formation transplant
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
JPH10194987A (ja) * 1997-01-14 1998-07-28 Youtai Iwamoto 骨・軟骨形成用組成物
US7041641B2 (en) * 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
EP0909954B1 (de) * 1997-10-16 2003-11-26 Scil Technology Holding GmbH Nachweis von Knorpelerkrankungen mit MIA

Also Published As

Publication number Publication date
EP1146897A1 (en) 2001-10-24
US6890897B1 (en) 2005-05-10
ES2180514T3 (es) 2003-02-16
CA2361238A1 (en) 2000-08-03
DE60000501T2 (de) 2003-02-13
AU765929B2 (en) 2003-10-02
DK1146897T3 (da) 2003-02-03
AU2799000A (en) 2000-08-18
JP2011084574A (ja) 2011-04-28
EP1025871A1 (en) 2000-08-09
CA2361238C (en) 2010-08-10
JP4800483B2 (ja) 2011-10-26
DE60000501D1 (de) 2002-10-31
EP1146897B1 (en) 2002-09-25
WO2000044401A1 (en) 2000-08-03
ATE224731T1 (de) 2002-10-15
JP2002537229A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
PT1146897E (pt) Utilizacao de um factor de actividade inibidora de melanomas (mia) para reparacao de cartilagem e de osso
FR2715309B1 (fr) Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
BR9706949A (pt) Composições desinfetantes e processos para desinfecção de superfícies
BR9706945A (pt) Composições desinfetantes e processos para disinfecção de superfícies
UY25157A1 (es) Composiciones farmacéuticas conteniendo atorvastatina y amlodipino
BR9701335A (pt) Novos inibidores de reabsorçao dos ossos e antagonistas do receptor vitronectina
ATE335438T1 (de) Nagel und schraube für chirurgisches fixationssystem
DE69922075D1 (de) Orthopädische Knochenplatte
DE69723080D1 (de) Chirurgische implantate und deren anbringungssysteme
PT733109E (pt) Proteinas morfogeneticas dos 0ss0s pmo-12 e pmo-13 e as suas composicoes para inducao de tendao
BR9704072A (pt) Derivados de cicloalquila como inibidores de ressorção de ossos e antagonistas de receptores vitronectina
DE69734615D1 (de) Knochenschraube mit Gelenkkippdübel
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
EE9900006A (et) Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena
BR9707699A (pt) Composições desinfetantes e processos para desinfetar superfícies
BR9707610A (pt) Composições desinfetantes e processos para desinfecção de superfícies
SE9904377D0 (sv) Pharmaceutical combinations
AR016981A2 (es) Polipeptidos sinteticos
DE69715701D1 (de) Photopolymerisierbare Zusammensetzung und gehärtete, transparente Gegenstände
ATE299703T1 (de) Mmp-hemmer bei bindegewebserweichung
BR9709406A (pt) Fluorenomas alquiloxiamino substituídas e seu uso como inibidores da proteína cinase-c
ATA62697A (de) Tragvorrichtung für eine stromschiene zur speisung von leuchten
BR0012683A (pt) Antagonistas bicìclicos seletivos para a integrina alfavbeta3
NO20004798D0 (no) Barbitursyrederivat og forebyggende og terapeutisk middel for ben og brusk inneholdende det samme